Daniel Bedinger

Daniel Bedinger was instrumental in the launch of Carterra’s LSA platform, perfecting technology, applications, and methods and now leads the Carterra’s global Application Science team. He has over two decades of experience in the generation and characterization of therapeutic monoclonal antibodies—most notably at Xoma and Abgenix. Daniel earned his Ph.D. from UC Davis in Molecular, Cellular, and Integrative Physiology.